Physiomics, the oncology consultancy using mathematical models and its Virtual Tumour™ technology to support the development of cancer treatment regimens and personalised medicine solutions, has today announced the completion of an £0.83m over-subscribed fundraise at 3.5p. This includes Director participation and the arrival of the Company’s first small-cap institutional fund onto the register.
27 May 2020
£0.8m oversubscribed placing,significant contract with large pharma company in the pipeline.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
£0.8m oversubscribed placing,significant contract with large pharma company in the pipeline.
Physiomics Plc (PYC:LON) | 1.6 0 14.8% | Mkt Cap: 2.10m
- Published:
27 May 2020 -
Author:
Derren Nathan -
Pages:
7
Physiomics, the oncology consultancy using mathematical models and its Virtual Tumour™ technology to support the development of cancer treatment regimens and personalised medicine solutions, has today announced the completion of an £0.83m over-subscribed fundraise at 3.5p. This includes Director participation and the arrival of the Company’s first small-cap institutional fund onto the register.